TradeStation President John Bartleman: Cryptocurrency "Here to Stay"
Cryptocurrency has investors in a frenzy, with some swearing by it, and others warning of instability and bubbles. In the pro-crypto camp is John Bartleman, president at digital brokerage firm TradeStation, who believes that digital currency is the future.
“I think this is here to stay, I think we are in the early days, somewhat like the internet in the early 80s, early 90s” he said.
Bitcoin is the top cryptocurrency now, shooting up the charts and, in a matter of weeks, jumping from $8,000 to over $11,000. Some analysts say there’s no reason for the hike, and swear the bubble is about to burst.
JPMorgan's Jamie Dimon, one of the most notable naysayers, says the Bitcoin currency is a fraudulent system, too often used for illicit purposes. Similarly, the CBOE recently announced it will launch Bitcoin futures trading as of December 10th, offering free trading through the month of December. The exchange says the move will provide “transparency, efficient price discovery, deep liquidity, and centralized clearing,” to investors.
Bartleman does agree that there is a lot of fraud as of now, and that the digital currency can see a correction, but he contends that “there’s real value in [crypto].”
“In the next five years, I think we will find ourselves in a place where retail customers will be interactive, trading in different type of crypto companies,” Bartleman said.
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.